Being a new mother has many challenges, including dermatological changes.
Stretch marks affect up to 90% of pregnant women.
This week's edition of the Mainstream Patient features stories about adult acne, Native American beauty products, a non-irritating retinol serum, beauty brands that support abortion rights, and more.
Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.
A study published in JAAD International examined the association between psoriasis and adverse pregnancy outcomes (APOs) and found that providers should be on the lookout for ectopic pregnancies (EP) in this population.
First clinical results for the treatment of central centrifugal cicatricial alopecia in Black women introduce more inclusive solutions.
Study finds women diagnosed with malignant melanoma during their pregnancy or within one year of giving birth were more than five times more likely to die than women who weren't pregnant. Routine skin examinations may need to be included as part of postpartum appointments.
Eight years after the Women's Health Initiative (WHI) linked estrogen supplementation to breast cancer and heart disease, the impact of estrogen withdrawal is obvious in a less-than-obvious location; hormone-deficient vulvar disease is becoming more common, according to F. William Danby, M.D.
The use of bioidentical hormone replacement therapy (BHRT) in dermatology is preferable to using synthetic hormones because potential overdose is less hazardous, and bioidentical hormones are not known to be carcinogenic, says Julie T. Hunter, M.D., founder and director of Wholistic Dermatology in Beverly Hills, Calif.
A systematic approach helps to guide the workup and management of female pattern alopecia (FPA), according to Mary Gail Mercurio, M.D.